Medscape One-on-One: John C. Reed

Medscape One-on-One: John Reed

Former FDA Chief on Modernizing Drug and Device Approvals Former FDA Commissioner Andrew C. von Eschenbach talks about bringing the drug and device approval process into the 21st century.
Medscape One-on-One, October 15, 2012

Three Promising Ideas in Psychiatric Drug Development Dr. John Reed interviews NIMH Director Dr. Thomas Insel on advancements being made in the diagnosis and treatment of neuropsychiatric disorders.
Medscape One-on-One, September 21, 2012
New AMA Head on Membership, the ACA, and Medicine's Future Dr. James Madara, of the American Medical Association, gives a candid interview on the nation's largest physician organization and whether it has any regrets about supporting the Affordable Care Act.
Medscape One-on-One, May 9, 2012
Topol on The Creative Destruction of Medicine The biggest shake-up in the history of medicine is coming and most doctors aren't ready. Dr. Eric Topol tells Dr. John Reed how physicians can prepare.
Medscape One-on-One, April 13, 2012
Francis Collins: 3 Scientific Breakthroughs Changing Medicine John C. Reed of the Sanford-Burnham Institute interviews NIH head Francis Collins on why doctors should get excited about the science of medicine.
Medscape One-on-One, February 15, 2012

John C. Reed, MD, PhD,
Chief Executive Officer
Professor
Donald Bren Chief Executive Chair
Sanford-Burnham Medical Research Institute
La Jolla, California
John C. Reed, MD, PhD, is Chief Executive Officer, Professor, and Donald Bren Executive Chair at Sanford-Burnham Medical Research Institute, where he has worked as a scientist and leader for more than 15 years.

Dr. Reed's research team studies the basic mechanisms that determine when cells live and when they die and, more important, how these systems go awry in diseases such as cancer. Advances in Dr. Reed's laboratory have resulted in a new cancer therapy that is now in final phase 3 clinical trials, as well as in a number of drug-discovery programs at earlier stages of development for cancer, stroke, and autoimmune diseases.

Dr. Reed has authored more than 800 research publications. The Institute for Scientific Information recognized Dr. Reed as the world's most cited scientist from 1995 to 2005 in the fields of cell biology and general biomedicine. Thomson Scientific named him one of its top 10 "Doctors of the Decade, 1995-2005." Dr. Reed is an inventor on more than 90 patents and is the founder or cofounder of 4 biotechnology companies. In 2011, he was elected fellow of the American Association for the Advancement of Science.